First Time Loading...

West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 365.48 USD 0.13%
Updated: May 6, 2024

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on May 6, 2024.

Estimated DCF Value of one WST stock is 134.05 USD. Compared to the current market price of 365.48 USD, the stock is Overvalued by 63%.

WST DCF Value
Base Case
134.05 USD
Overvaluation 63%
DCF Value
Price
Worst Case
Base Case
Best Case
134.05
DCF Value
Worst Case
Base Case
Best Case
Hide
DCF Value: 134.05 USD

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to 3B USD. The present value of the terminal value is 6.1B USD. The total present value equals 9B USD.
Forecast Period
Years
Discount Rate
%
Show All DCF Settings
Terminal Growth
%
Hide DCF Settings
Save

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value 9B USD
+ Cash & Equivalents 601.8m USD
+ Investments 202.5m USD
Firm Value 9.8B USD
- Debt 72.8m USD
Equity Value 9.8B USD
/ Shares Outstanding 72.8m
WST DCF Value 134.05 USD
Overvalued by 63%

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

Revenue
3.1B 4.3B
Operating Income
703.7m 1.1B
FCFF
626m 885.2m

See Also

Discover More

What is the DCF value of one WST stock?

Estimated DCF Value of one WST stock is 134.05 USD. Compared to the current market price of 365.48 USD, the stock is Overvalued by 63%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, West Pharmaceutical Services Inc's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at 9B USD.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of 134.05 USD per share.

//